Mirae Asset Global Etfs Holdings Ltd. Wave Life Sciences Ltd. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $41.5 Billion
- Q3 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 42,485 shares of WVE stock, worth $565,900. This represents 0.0% of its overall portfolio holdings.
Number of Shares
42,485
Previous 37,421
13.53%
Holding current value
$565,900
Previous $186,000
87.1%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding WVE
# of Institutions
164Shares Held
117MCall Options Held
148KPut Options Held
109K-
Ra Capital Management, L.P. Boston, MA18.2MShares$242 Million2.08% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx10MShares$134 Million1.71% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA9.7MShares$129 Million0.15% of portfolio
-
Black Rock Inc. New York, NY6.74MShares$89.8 Million0.0% of portfolio
-
M28 Capital Management LP Stamford, CT6.16MShares$82.1 Million48.05% of portfolio
About Wave Life Sciences Ltd.
- Ticker WVE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,820,096
- Market Cap $1.16B
- Description
- Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...